CIA and its members fully support the 3Rs principle (replacement, reduction, and refinement of animal tests). Our members are working to develop and validate non-animal testing methods.
Chemical regulations can require the testing of chemical substances on vertebrates to ensure safety of consumers, workers, and the environment. Many jurisdictions have therefore enshrined the 3Rs principle within their legislation to limit this, e.g. in both UK and Europe it is embedded within REACH (Registration, Evaluation, Authorisation and restriction of Chemicals), CLP (Classification, Labelling and Packaging) Regulations and in sectoral legislations.
Following publication in November 2024 by the Health and Safety Executive of guidance on minimising animal testing in UK-REACH, the government published a Strategy in November 2025 on ‘Replacing Animals in Science: A Strategy to Support the Development, Validation and Uptake of Alternative Methods’. A key objective of this is to raise awareness and increase the regulatory acceptance of New Approach Methodologies (NAMs). NAMs are any non-animal approach used on its own, or with others to demonstrate the safe use of a chemical substance.
With the publication of the UK Strategy, the opportunity is here now for the UK science community to be at the forefront and lead the way towards better testing strategies globally. The chemicals sector strongly encourages the UK government to maximise this prospect.
ACTIONS (for authorities):
· Continue to develop and implement the UK Strategy on ‘Replacing Animals in Science’ for supporting the “Development, Validation and Uptake of Alternative Methods”.
· ‘Champion’ the regulatory acceptance of NAMs by establishing an international programme beyond that of OECD, for validation and promotion of these with the aim of achieving multi-regulatory acceptance and use across all regulations.
· Promote the use of NAMs for demonstrating the safe use of a chemical substance through science, especially when evaluating grouping and read-across, or through adoption of novel risk-based Next Generation Risk Assessment (NGRA) approaches and Integrated Approaches for Testing and Assessment (IATA).
· Support targeted pragmatic testing approaches, that ensure industry is not asked to conduct or repeat any animal test(s) where reliable data already exists (including through substance grouping or read across). Industry does not agree with a ‘tick box’ approach to fill data gaps, nor that (eco)toxicity testing/data needs should be linked to production/import volume as a proxy for exposure.
· Request additional information that involves animal testing only when it is absolutely necessary, thereby adhering to the last resort principles enshrined by Articles 13 and 25 of UK/EU REACH.
For further information see our Position statement.
POLICY AREA: Chemicals Management
WEBSITE LOCATION: Our Asks
TITLE: Reducing and Refining the Reliance on Animal Testing in
Chemicals Regulation
CIA and its members fully support the 3Rs principle (replacement, reduction, and refinement
of animal tests). Our members are working to develop and validate non-animal testing
methods.
Chemical regulations can require the testing of chemical substances on vertebrates to
ensure safety of consumers, workers, and the environment. Many jurisdictions have
therefore enshrined the 3Rs principle within their legislation to limit this, e.g. in both UK and
Europe it is embedded within REACH (Registration, Evaluation, Authorisation and restriction
of Chemicals), CLP (Classification, Labelling and Packaging) Regulations and in sectoral
legislations.
Following publication in November 2024 by the Health and Safety Executive of guidance on
minimising animal testing in UK-REACH, the government published a Strategy in November
2025 on ‘Replacing Animals in Science: A Strategy to Support the Development, Validation
and Uptake of Alternative Methods’. A key objective of this is to raise awareness and
increase the regulatory acceptance of New Approach Methodologies (NAMs). NAMs are any
non-animal approach used on its own, or with others to demonstrate the safe use of a
chemical substance.
With the publication of the UK Strategy, the opportunity is here now for the UK science
community to be at the forefront and lead the way towards better testing strategies globally.
The chemicals sector strongly encourages the UK government to maximise this prospect.
ACTIONS (for authorities):
• Continue to develop and implement the UK Strategy on ‘Replacing Animals in Science’
for supporting the “Development, Validation and Uptake of Alternative Methods”.
• ‘Champion’ the regulatory acceptance of NAMs by establishing an international
programme beyond that of OECD, for validation and promotion of these with the aim of
achieving multi-regulatory acceptance and use across all regulations.
DRAFT
• Promote the use of NAMs for demonstrating the safe use of a chemical substance
through science, especially when evaluating grouping and read-across, or through
adoption of novel risk-based Next Generation Risk Assessment (NGRA) approaches
and Integrated Approaches for Testing and Assessment (IATA).
• Support targeted pragmatic testing approaches, that ensure industry is not asked to
conduct or repeat any animal test(s) where reliable data already exists (including
through substance grouping or read across). Industry does not agree with a ‘tick box’
approach to fill data gaps, nor that (eco)toxicity testing/data needs should be linked to
production/import volume as a proxy for exposure.
• Request additional information that involves animal testing only when it is absolutely
necessary, thereby adhering to the last resort principles enshrined by Articles 13 and 25
of UK/EU REACH.
For further information see our Position statement.